PT3866767T - Composição farmacêutica para administração oral que inclui um derivado de aminopirimidina ou o seu sal - Google Patents
Composição farmacêutica para administração oral que inclui um derivado de aminopirimidina ou o seu salInfo
- Publication number
- PT3866767T PT3866767T PT198724270T PT19872427T PT3866767T PT 3866767 T PT3866767 T PT 3866767T PT 198724270 T PT198724270 T PT 198724270T PT 19872427 T PT19872427 T PT 19872427T PT 3866767 T PT3866767 T PT 3866767T
- Authority
- PT
- Portugal
- Prior art keywords
- salt
- pharmaceutical composition
- oral administration
- aminopyrimidine derivative
- aminopyrimidine
- Prior art date
Links
- 150000005005 aminopyrimidines Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180124171A KR20200043618A (ko) | 2018-10-18 | 2018-10-18 | 아미노피리미딘 유도체 또는 이의 염을 포함하는 경구투여용 약학 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3866767T true PT3866767T (pt) | 2024-01-18 |
Family
ID=70282933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT198724270T PT3866767T (pt) | 2018-10-18 | 2019-10-17 | Composição farmacêutica para administração oral que inclui um derivado de aminopirimidina ou o seu sal |
Country Status (29)
Country | Link |
---|---|
US (1) | US20210322428A1 (pt) |
EP (2) | EP3866767B1 (pt) |
JP (2) | JP7369769B2 (pt) |
KR (2) | KR20200043618A (pt) |
CN (1) | CN113015521A (pt) |
AR (1) | AR117655A1 (pt) |
AU (1) | AU2019360446A1 (pt) |
BR (1) | BR112021007061A2 (pt) |
CA (1) | CA3116652A1 (pt) |
DK (1) | DK3866767T3 (pt) |
EA (1) | EA202191061A1 (pt) |
ES (1) | ES2968966T3 (pt) |
FI (1) | FI3866767T3 (pt) |
HR (1) | HRP20231670T1 (pt) |
HU (1) | HUE065389T2 (pt) |
IL (1) | IL282163A (pt) |
LT (1) | LT3866767T (pt) |
MA (1) | MA53927B1 (pt) |
MD (1) | MD3866767T2 (pt) |
MX (2) | MX2021004457A (pt) |
PE (1) | PE20211818A1 (pt) |
PH (1) | PH12021550687A1 (pt) |
PL (1) | PL3866767T3 (pt) |
PT (1) | PT3866767T (pt) |
RS (1) | RS65012B1 (pt) |
SG (1) | SG11202103057RA (pt) |
SI (1) | SI3866767T1 (pt) |
TW (1) | TWI831848B (pt) |
WO (1) | WO2020079637A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020230091A1 (en) | 2019-05-14 | 2020-11-19 | Janssen Biotech, Inc. | Combination therapies with bispecific anti-egfr/c-met antibodies and third generation egfr tyrosine kinase inhibitors |
US11850248B2 (en) | 2019-05-14 | 2023-12-26 | Yuhan Corporation | Therapies with 3rd generation EGFR tyrosine kinase inhibitors |
TW202207940A (zh) * | 2020-04-14 | 2022-03-01 | 美商健生生物科技公司 | 包含胺基嘧啶衍生物或其醫藥上可接受之鹽、水合物、或溶劑化物之用於經口投予之醫藥組成物 |
WO2022253261A1 (zh) | 2021-06-01 | 2022-12-08 | 杭州领业医药科技有限公司 | Lazertinib甲磺酸盐的水合物晶型及其制备方法和用途 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0103000A3 (en) * | 1998-07-20 | 2002-08-28 | Smithkline Beecham Corp | Bioenhanced formulations comprising eprosartan in oral solid dosage form and process for their preparation |
DE10319450A1 (de) | 2003-04-30 | 2004-11-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung des Telmisartan Natriumsalzes |
WO2008057266A2 (en) | 2006-10-27 | 2008-05-15 | Fmc Corporation | Dry granulation binders, products, and use thereof |
ES2359377T3 (es) * | 2006-10-27 | 2011-05-23 | Fmc Corporation | Celulosa microcristalina coprocesada y alcohol de azúcar como excipiente para formulaciones de comprimidos. |
US11453646B2 (en) * | 2011-07-27 | 2022-09-27 | Cornell University | Methods for RNA detection and quantification |
US9884042B2 (en) | 2011-09-14 | 2018-02-06 | Celgene Corporation | Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide |
KR101560994B1 (ko) | 2011-11-29 | 2015-10-15 | 길리어드 파마셋 엘엘씨 | 간염 c 바이러스 치료를 위한 조성물 및 방법 |
US9539098B2 (en) * | 2013-04-23 | 2017-01-10 | Rev Ortho Llc | System for modular hip resurfacing |
GB201400034D0 (en) | 2014-01-02 | 2014-02-19 | Astrazeneca Ab | Pharmaceutical Compositions comprising AZD9291 |
HUE054848T2 (hu) | 2014-10-13 | 2021-09-28 | Yuhan Corp | Vegyületek és készítmények EGFR mutáns kináz aktivitás módosítására |
SG10202010389TA (en) | 2014-12-16 | 2020-11-27 | Signal Pharm Llc | Formulations of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methycyclohexylamino)-pyrimidine-5-carboxamide |
CN104788427B (zh) * | 2015-02-05 | 2017-05-31 | 上海泓博智源医药股份有限公司 | 3‑(2‑嘧啶氨基)苯基丙烯酰胺类化合物及其应用 |
KR20180008511A (ko) | 2015-05-22 | 2018-01-24 | 노파르티스 아게 | 제약 조성물 |
WO2017061621A1 (ja) | 2015-10-07 | 2017-04-13 | 協和発酵キリン株式会社 | アリールアルキルアミン化合物含有医薬組成物 |
RU2745195C2 (ru) | 2016-04-07 | 2021-03-22 | Кемосентрикс, Инк. | Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами |
AR111469A1 (es) * | 2017-04-21 | 2019-07-17 | Yuhan Corp | Sal de un compuesto del derivado de aminopiridina, una forma cristalina de la misma, y un proceso para preparar la misma |
TW202207940A (zh) * | 2020-04-14 | 2022-03-01 | 美商健生生物科技公司 | 包含胺基嘧啶衍生物或其醫藥上可接受之鹽、水合物、或溶劑化物之用於經口投予之醫藥組成物 |
-
2018
- 2018-10-18 KR KR1020180124171A patent/KR20200043618A/ko unknown
-
2019
- 2019-10-17 RS RS20231252A patent/RS65012B1/sr unknown
- 2019-10-17 EP EP19872427.0A patent/EP3866767B1/en active Active
- 2019-10-17 PT PT198724270T patent/PT3866767T/pt unknown
- 2019-10-17 WO PCT/IB2019/058862 patent/WO2020079637A1/en active Application Filing
- 2019-10-17 HR HRP20231670TT patent/HRP20231670T1/hr unknown
- 2019-10-17 LT LTEPPCT/IB2019/058862T patent/LT3866767T/lt unknown
- 2019-10-17 BR BR112021007061-3A patent/BR112021007061A2/pt unknown
- 2019-10-17 MX MX2021004457A patent/MX2021004457A/es unknown
- 2019-10-17 PL PL19872427.0T patent/PL3866767T3/pl unknown
- 2019-10-17 HU HUE19872427A patent/HUE065389T2/hu unknown
- 2019-10-17 MA MA53927A patent/MA53927B1/fr unknown
- 2019-10-17 SG SG11202103057RA patent/SG11202103057RA/en unknown
- 2019-10-17 US US17/285,161 patent/US20210322428A1/en active Pending
- 2019-10-17 JP JP2021520564A patent/JP7369769B2/ja active Active
- 2019-10-17 EP EP23211951.1A patent/EP4306113A3/en active Pending
- 2019-10-17 EA EA202191061A patent/EA202191061A1/ru unknown
- 2019-10-17 KR KR1020217014600A patent/KR20210061457A/ko unknown
- 2019-10-17 ES ES19872427T patent/ES2968966T3/es active Active
- 2019-10-17 CN CN201980068641.1A patent/CN113015521A/zh active Pending
- 2019-10-17 MD MDE20210799T patent/MD3866767T2/ro unknown
- 2019-10-17 TW TW108137395A patent/TWI831848B/zh active
- 2019-10-17 AU AU2019360446A patent/AU2019360446A1/en active Pending
- 2019-10-17 SI SI201930673T patent/SI3866767T1/sl unknown
- 2019-10-17 PE PE2021000495A patent/PE20211818A1/es unknown
- 2019-10-17 FI FIEP19872427.0T patent/FI3866767T3/fi active
- 2019-10-17 CA CA3116652A patent/CA3116652A1/en active Pending
- 2019-10-17 DK DK19872427.0T patent/DK3866767T3/da active
- 2019-10-18 AR ARP190102972A patent/AR117655A1/es unknown
-
2021
- 2021-03-25 PH PH12021550687A patent/PH12021550687A1/en unknown
- 2021-04-08 IL IL282163A patent/IL282163A/en unknown
- 2021-04-16 MX MX2023014946A patent/MX2023014946A/es unknown
-
2023
- 2023-10-16 JP JP2023177976A patent/JP2024016052A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL282163A (en) | A pharmaceutical preparation for oral administration containing an aminopyrimidine derivative or its salt | |
IL270812A (en) | Solid compositions for oral drug administration | |
HK1248544A1 (zh) | 穩定的口服給藥用藥物組合物 | |
EP3851121A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY | |
IL290469A (en) | Oral pharmaceutical preparation | |
HK1245646A1 (zh) | 口服給藥用醫藥組合物 | |
GB202103764D0 (en) | Pharmaceutical suspension for oral dosage | |
PT3632436T (pt) | Composição farmacêutica compreendendo sais de lenvatinib | |
HK1243351A1 (zh) | 一種含有吡啶並嘧啶類衍生物或其可藥用鹽的藥物組合物 | |
SG11202101547WA (en) | Pharmaceutical composition for oral administration | |
HUE062682T2 (hu) | Ibuprofén tartalmú orális gyógyszerészeti készítmény | |
SI3778609T1 (sl) | Derivati penama ali njenih soli, farmacevtski sestavki in njihova uporaba | |
EP3650024A4 (en) | PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION | |
GB2569616B (en) | Sustained release oral pharmaceutical compositions of dicycloverine | |
ZA201803722B (en) | Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof |